James T. Palmer

Discovery of Selective Irreversible Inhibitors for Bruton’s Tyrosine Kinase

Zhengying Pan, Heleen Scheerens, Shyr‐Jiann Li et al. · ChemMedChem · 2006 · 669 citations

Rheumatoid Disorder, Molecular Pharmacology, Medicinal Chemistry +14

Vinyl Sulfones as Mechanism-Based Cysteine Protease Inhibitors

James T. Palmer, David Rasnick, Jeffrey L. Klaus et al. · Journal of Medicinal Chemistry · 1995 · 504 citations · Full text

Pharmaceutical Science, Bioorganic Chemistry, Altmetric Attention Score +17

The discovery of odanacatib (MK-0822), a selective inhibitor of cathepsin K

Jacques Yves Gauthier, Nathalie Chauret, Wanda Cromlish et al. · Bioorganic & Medicinal Chemistry Letters · 2008 · 467 citations · Full text

Molecular Pharmacology, Pharmaceutical Chemistry, Biochemistry +11

VEGF antagonism reduces edema formation and tissue damage after ischemia/reperfusion injury in the mouse brain

Nicholas van Bruggen, Harold Thibodeaux, James T. Palmer et al. · Journal of Clinical Investigation · 1999 · 459 citations · Full text

Immunology, Cell Death, Edematous Tissue 1 +24

Cathepsin S activity regulates antigen presentation and immunity.

Richard J. Riese, Richard Mitchell, Jóse A. Villadangos et al. · Journal of Clinical Investigation · 1998 · 313 citations · Full text

Immune Regulation, Immunology, Antigen Processing +16